-
(18S)-18-[(dimethylamino)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione hydrochloride
-
ChemBase ID:
177651
-
Molecular Formular:
C28H29ClN4O3
-
Molecular Mass:
505.00786
-
Monoisotopic Mass:
504.19281849
-
SMILES and InChIs
SMILES:
C12=C(C(=O)NC1=O)c1c3c(cccc3)n(c1)CC[C@H](OCCn1c3ccccc3c2c1)CN(C)C.Cl
Canonical SMILES:
CN(C[C@H]1OCCn2cc(c3c2cccc3)C2=C(c3cn(CC1)c1ccccc31)C(=O)NC2=O)C.Cl
InChI:
InChI=1S/C28H28N4O3.ClH/c1-30(2)15-18-11-12-31-16-21(19-7-3-5-9-23(19)31)25-26(28(34)29-27(25)33)22-17-32(13-14-35-18)24-10-6-4-8-20(22)24;/h3-10,16-18H,11-15H2,1-2H3,(H,29,33,34);1H/t18-;/m0./s1
InChIKey:
NYQIEYDJYFVLPO-FERBBOLQSA-N
-
Cite this record
CBID:177651 http://www.chembase.cn/molecule-177651.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
(18S)-18-[(dimethylamino)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione hydrochloride
|
|
|
|
|
IUPAC Traditional name
|
|
ruboxistaurin hydrochloride
|
|
|
|
|
Synonyms
|
|
(9S)-9-[[(Dimethyl-d6)amino]methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-Dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione Hydrochloride
|
|
LY 333531-d6
|
|
Ruboxistaurin-d6 Hydrochloride
|
|
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
|
Data Source
|
Data ID
|
Price
|
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
9.761606
|
H Acceptors
|
4
|
H Donor
|
1
|
LogD (pH = 5.5)
|
0.17880318
|
LogD (pH = 7.4)
|
1.8527069
|
Log P
|
2.9780278
|
Molar Refractivity
|
135.8512 cm3
|
Polarizability
|
54.24105 Å3
|
Polar Surface Area
|
68.5 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
false
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
R701527
|
|
Labelled Ruboxistaurin. Ruboxistaurin is a protein kinase C (PKC) β inhibitor, exhibits significant anti-angiogenic activity that reduces the response of vascular endothelial cells to stimulation by vascular endothelial growth factor (VEGF). Ruboxistaurin |
PATENTS
PATENTS
PubChem Patent
Google Patent